Literature DB >> 24139614

End-diastolic flow reversal limits the efficacy of pediatric intra-aortic balloon pump counterpulsation.

Carlo R Bartoli1, Benjamin D Rogers2, Constantine E Ionan3, George M Pantalos4.   

Abstract

BACKGROUND: Counterpulsation with an intra-aortic balloon pump (IABP) has not achieved the same success or clinical use in pediatric patients as in adults. In a pediatric animal model, IABP efficacy was investigated to determine whether IABP timing with a high-fidelity blood pressure signal may improve counterpulsation therapy versus a low-fidelity signal.
METHODS: In Yorkshire piglets (n = 19; weight, 13.0 ± 0.5 kg) with coronary ligation-induced acute ischemic left ventricular failure, pediatric IABPs (5 or 7 mL) were placed in the descending thoracic aorta. Inflation and deflation were timed with traditional criteria from low-fidelity (fluid-filled) and high-fidelity (micromanometer) blood pressure signals during 1:1 support. Aortic, carotid, and coronary hemodynamics were measured with pressure and flow transducers. Myocardial oxygen consumption was calculated from coronary sinus and arterial blood samples. Left ventricular myocardial blood flow and end-organ blood flow were measured with microspheres.
RESULTS: Despite significant suprasystolic diastolic augmentation and afterload reduction at heart rates of 105 ± 3 beats per minute, left ventricular myocardial blood flow, myocardial oxygen consumption, the myocardial oxygen supply/demand relationship, cardiac output, and end-organ blood flow did not change. Statistically significant end-diastolic coronary, carotid, and aortic flow reversal occurred with IABP deflation. Inflation and deflation timed with a high-fidelity versus low-fidelity signal did not attenuate systemic flow reversal or improve the myocardial oxygen supply/demand relationship.
CONCLUSIONS: Systemic end-diastolic flow reversal limited counterpulsation efficacy in a pediatric model of acute left ventricular failure. Adjustment of IABP inflation and deflation timing with traditional criteria and a high-fidelity blood pressure waveform did not improve IABP efficacy or attenuate flow reversal. End-diastolic flow reversal may limit the efficacy of IABP counterpulsation therapy in pediatric patients with traditional timing criteria. Investigation of alternative deflation timing strategies is warranted.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24139614      PMCID: PMC3988268          DOI: 10.1016/j.jtcvs.2013.08.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  26 in total

1.  Counterpulsation with symphony prevents retrograde carotid, aortic, and coronary flows observed with intra-aortic balloon pump support.

Authors:  Guruprasad A Giridharan; Carlo R Bartoli; Paul A Spence; Robert D Dowling; Steven C Koenig
Journal:  Artif Organs       Date:  2012-05-16       Impact factor: 3.094

2.  Response to single-segment intraaortic balloon pumping as related to aortic compliance.

Authors:  C Y Lin; F T Galysh; K J Ho; A S Patel
Journal:  Ann Thorac Surg       Date:  1972-05       Impact factor: 4.330

3.  Estimation of timing errors for the intraaortic balloon pump use in pediatric patients.

Authors:  G M Pantalos; L L Minich; L Y Tani; E C McGough; J A Hawkins
Journal:  ASAIO J       Date:  1999 May-Jun       Impact factor: 2.872

4.  A novel approach to pediatric intraaortic balloon pump timing using M-mode echocardiography.

Authors:  L L Minich; L Y Tani; E C McGough; R E Shaddy; J A Hawkins
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

Review 5.  The role of the Intra-aortic balloon pump in supporting children with acute cardiac failure.

Authors:  Sathiakar Paul Collison; Kulbhusan Singh Dagar
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

6.  Neonatal piglet model of intraaortic balloon pumping: improved efficacy using echocardiographic timing.

Authors:  L L Minich; L Y Tani; G M Pantalos; B L Bolland; B K Knorr; J A Hawkins
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

7.  Repeat microsphere delivery for serial measurement of regional blood perfusion in the chronically instrumented, conscious canine.

Authors:  Carlo R Bartoli; Kazunori Okabe; Ichiro Akiyama; Brent Coull; John J Godleski
Journal:  J Surg Res       Date:  2007-07-16       Impact factor: 2.192

8.  Mechanism of myocardial ischemia with an anomalous left coronary artery from the right sinus of Valsalva.

Authors:  Carlo R Bartoli; William B Wead; Guruprasad A Giridharan; Sumanth D Prabhu; Steven C Koenig; Robert D Dowling
Journal:  J Thorac Cardiovasc Surg       Date:  2012-05-05       Impact factor: 5.209

9.  The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database.

Authors:  Ryan R Davies; Mark J Russo; Kimberly N Hong; Michael L O'Byrne; David P Cork; Alan J Moskowitz; Annetine C Gelijns; Seema Mital; Ralph S Mosca; Jonathan M Chen
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 5.209

10.  Integrated data acquisition system for medical device testing and physiology research in compliance with good laboratory practices.

Authors:  Steven C Koenig; Cary Woolard; Guy Drew; Lauren Unger; Kevin Gillars; Dan Ewert; Laman Gray; George Pantalos
Journal:  Biomed Instrum Technol       Date:  2004 May-Jun
View more
  2 in total

1.  A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patients.

Authors:  V Vivian Dimas; Brian H Morray; Dennis W Kim; Christopher S Almond; Shabana Shahanavaz; Sebastian C Tume; Lynn F Peng; Doff B McElhinney; Henri Justino
Journal:  Catheter Cardiovasc Interv       Date:  2017-03-15       Impact factor: 2.692

Review 2.  Technology landscape of pediatric mechanical circulatory support devices: A systematic review 2010-2021.

Authors:  Thomas Palazzolo; Matthew Hirschhorn; Ellen Garven; Steven Day; Randy M Stevens; Joseph Rossano; Vakhtang Tchantchaleishvili; Amy L Throckmorton
Journal:  Artif Organs       Date:  2022-04-14       Impact factor: 2.663

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.